PMS40 COST-EFFECTIVENESS OF DENOSUMAB COMPARED WITH GENERIC ALENDRONATE IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROTIC WOMEN
Nov 1, 2010, 00:00
10.1016/S1098-3015(11)72193-3
https://www.valueinhealthjournal.com/article/S1098-3015(11)72193-3/fulltext
Title :
PMS40 COST-EFFECTIVENESS OF DENOSUMAB COMPARED WITH GENERIC ALENDRONATE IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROTIC WOMEN
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)72193-3&doi=10.1016/S1098-3015(11)72193-3
First page :
A309
Section Title :
RESEARCH POSTER ABSTRACTS
Open access? :
No
Section Order :
351